These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8369380)

  • 21. Hepatitis B immunity in adolescents and necessity for boost vaccination: 23 years after nationwide hepatitis B virus vaccination program in Taiwan.
    Lu JJ; Cheng CC; Chou SM; Hor CB; Yang YC; Wang HL
    Vaccine; 2009 Nov; 27(47):6613-8. PubMed ID: 19698812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Persistence of HB vaccine immune protection and response to hepatitis B booster immunization].
    Li H; Li R; Liao S; Yang J; Zeng X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Feb; 20(1):54-9. PubMed ID: 11367735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the routine hepatitis B immunization programme in Palestine, 1996.
    Kuhail S; el-Khodary R; Ahmed F
    East Mediterr Health J; 2000; 6(5-6):864-9. PubMed ID: 12197342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination.
    Williams IT; Goldstein ST; Tufa J; Tauillii S; Margolis HS; Mahoney FJ
    Pediatr Infect Dis J; 2003 Feb; 22(2):157-63. PubMed ID: 12586980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-HBs profiles in children treated for neoplastic disease who had been vaccinated against hepatitis B postnatally or as infants.
    Koltan S; Koltan A; Wysocki M; Debski R; Styczynski J
    J Hosp Infect; 2005 May; 60(1):73-7. PubMed ID: 15823661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique.
    Griffiths UK; Hutton G; Das Dores Pascoal E
    Health Policy Plan; 2005 Jan; 20(1):50-9. PubMed ID: 15689430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repeated-measures models to evaluate a hepatitis B vaccination programme.
    Renard D; Bruckers L; Molenberghs G; Vellinga A; Van Damme P
    Stat Med; 2001 Mar; 20(6):951-63. PubMed ID: 11252015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of vaccination against viral hepatitis type B in children with the nephrotic syndrome.
    Szajner-Milart I; Zajaczkowska M; Zinkiewicz Z; Borzecka H; Majewski M
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):402-8. PubMed ID: 15315023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term immunogenicity and efficacy of a recombinant hepatitis B vaccine in Egyptian children.
    el-Sawy IH; Mohamed ON
    East Mediterr Health J; 1999 Sep; 5(5):922-32. PubMed ID: 10983531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B immunization in infants of hepatitis B surface antigen-negative mothers.
    Chirico G; Belloni C; Gasparoni A; Cerbo RM; Rondini G; Klersy C; Orsolini P; Filice G
    Pediatrics; 1993 Nov; 92(5):717-9. PubMed ID: 8414862
    [No Abstract]   [Full Text] [Related]  

  • 31. Serum level of anti-hepatitis B surface antigen 6-8 years after hepatitis B vaccination at birth.
    Kazemi A; Koosha A; Rafizadeh B; Mousavinasab N; Mahram M
    East Mediterr Health J; 2008; 14(4):960-5. PubMed ID: 19166180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B vaccine.
    John TJ
    Indian Pediatr; 1995 Jun; 32(6):715-8. PubMed ID: 8613350
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatitis B vaccination and exposure protocol: update.
    Kelly M; Wisnom C
    Gen Dent; 1993; 41(6):531-4; quiz 535-7. PubMed ID: 23087949
    [No Abstract]   [Full Text] [Related]  

  • 34. [Long-term efficacy and persistence of Chinese infants after receiving only active plasma-derived hepatitis B vaccine].
    Xia G; Jia Z; Yan T; Li R; Liu H; Xu Z; Cao H; Liu C
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):146-9. PubMed ID: 12196826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.
    Hammitt LL; Hennessy TW; Fiore AE; Zanis C; Hummel KB; Dunaway E; Bulkow L; McMahon BJ
    Vaccine; 2007 Sep; 25(39-40):6958-64. PubMed ID: 17714836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response to hepatitis B virus vaccination in haemodialysis patients with and without hepatitis C infection.
    Sorkhi H; Roushan MR; Al Hashemi GH; Dooki MR; Bai S
    East Mediterr Health J; 2008; 14(4):798-803. PubMed ID: 19166162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents.
    Gabbuti A; Romanò L; Blanc P; Meacci F; Amendola A; Mele A; Mazzotta F; Zanetti AR
    Vaccine; 2007 Apr; 25(16):3129-32. PubMed ID: 17291637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serological response to hepatitis B virus vaccine in HIV-infected children in Tanzania.
    Pippi F; Bracciale L; Stolzuoli L; Giaccherini R; Montomoli E; Gentile C; Filetti S; De Luca A; Cellesi C
    HIV Med; 2008 Aug; 9(7):519-25. PubMed ID: 18554311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors associated with hepatitis B virus immunization coverage at the beginning of a population campaign in the Lazio region, Italy.
    Faustini A; Spadea T; Fano V; Giorgi Rossi P; Sangalli M; Franco E; Perucci CA
    Prev Med; 2001 Nov; 33(5):409-14. PubMed ID: 11676581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen.
    Huang LM; Chiang BL; Lee CY; Lee PI; Chi WK; Chang MH
    Hepatology; 1999 Mar; 29(3):954-9. PubMed ID: 10051503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.